Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
January 9, 2026 Off

Best Creatine Supplements for Women And Men 2026: Effective Creatine For Muscle Growth & Weight loss For Women Over 40, 50 – by Crazy Nutrition

By GlobeNewswire

Wondering what the Safe creatines for women in 2026 are? In this guide, a high-performance athlete and nutritionist helps you…

January 9, 2026 Off

Praxis Precision Medicines Further Positioned for Next-Phase Growth with Key Board and Executive Appointments

By GlobeNewswire

BOSTON, Jan. 08, 2026 (GLOBE NEWSWIRE) — Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights…

January 9, 2026 Off

Cellectis Announces 2026 Strategy and Catalysts

By GlobeNewswire

NEW YORK, Jan. 08, 2026 (GLOBE NEWSWIRE) — Cellectis (the “Company”) (Euronext Growth: ALCLS – NASDAQ: CLLS), a clinical-stage biotechnology…

January 9, 2026 Off

Septerna Expands Leadership with Appointment of Industry Veteran Mark A. Wilson as Chief Legal Officer

By GlobeNewswire

SOUTH SAN FRANCISCO, Calif., Jan. 08, 2026 (GLOBE NEWSWIRE) — Septerna, Inc. (Nasdaq: SEPN), a clinical-stage biotechnology company pioneering a…

January 9, 2026 Off

Spyre Therapeutics Announces Grants of Inducement Awards

By GlobeNewswire

WALTHAM, Mass., Jan. 08, 2026 (GLOBE NEWSWIRE) — Spyre Therapeutics, Inc. (NASDAQ: SYRE) (the “Company” or “Spyre”), a clinical-stage biotechnology…

January 9, 2026 Off

Tilray Brands Delivers Record Q2 Fiscal 2026 Net Revenue of $218 Million, Moves to Net Cash Position and Reaffirms Full-Year Adjusted EBITDA Guidance

By GlobeNewswire

International Medical Cannabis Revenue Increases 36%; Canadian Adult-Use Cannabis Revenue Grows 6% Tilray Pharma Achieves Record Quarterly Revenue U.S. Federal…

January 9, 2026 Off

Eledon Pharmaceuticals Highlights Recent Business Milestones and Provides 2026 Outlook

By GlobeNewswire

Phase 2 BESTOW trial data evaluating tegoprubart in kidney transplantation showed favorable efficacy, safety and tolerability, supporting advancement into Phase…

January 9, 2026 Off

ImmuCell Announces Preliminary, Unaudited Sales Results for Q4 and Full Year of 2025

By GlobeNewswire

PORTLAND, Maine, Jan. 08, 2026 (GLOBE NEWSWIRE) — ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), an animal health company…

January 9, 2026 Off

Tvardi Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference

By GlobeNewswire

Company to Highlight New Data from Phase 2 REVERT IPF Clinical Trial of TTI-101 in Podium PresentationHOUSTON, Jan. 08, 2026…

January 9, 2026 Off

Vaxart to Participate in the Global BioInnovation Forum on January 13, 2026

By GlobeNewswire

SOUTH SAN FRANCISCO, Jan. 08, 2026 (GLOBE NEWSWIRE) — Vaxart, Inc. (OTCQX: VXRT) (“Vaxart or “the Company”), a clinical-stage biotechnology…

Posts pagination

Previous 1 … 3 4 5 … 6,254 Next

Popular posts

Medicago, GSK report primary and secondary endpoints with available data met in trial dominated by COVID-19 variants

December 10, 2021 Off

Foghorn Therapeutics Highlights January Equity Financing, Program Progress and Strategic Objectives for 2026

January 11, 2026 Off
Cosentyx meets the primary endpoints

Cosentyx meets the primary endpoints

June 15, 2015 Off
Adapt Pharma rolls submision to NDA for naloxone-based nasal spray

Adapt Pharma rolls submision to NDA for naloxone-based nasal spray

June 15, 2015 Off
Strensiq in HPP patiens therapy get approval from European Commission

Strensiq in HPP patiens therapy get approval from European Commission

September 13, 2015 Off

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine